1. Home
  2. CULP vs PDSB Comparison

CULP vs PDSB Comparison

Compare CULP & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$3.56

Market Cap

43.8M

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.80

Market Cap

42.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CULP
PDSB
Founded
1972
2005
Country
United States
United States
Employees
N/A
10
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
42.4M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CULP
PDSB
Price
$3.56
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $9.00
AVG Volume (30 Days)
120.1K
★ 44.9M
Earning Date
03-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 47.06
28.16
EPS
★ 0.47
N/A
Revenue
★ $203,482,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.42
N/A
P/E Ratio
$7.47
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.70
$0.20
52 Week High
$4.50
$1.55

Technical Indicators

Market Signals
Indicator
CULP
PDSB
Relative Strength Index (RSI) 52.78 68.88
Support Level $3.19 $0.58
Resistance Level $3.59 $1.07
Average True Range (ATR) 0.19 0.14
MACD -0.01 0.05
Stochastic Oscillator 25.71 73.77

Price Performance

Historical Comparison
CULP
PDSB

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: